4D MOLECULAR THERAPEUTICS, INC.

Transcripts 4D Molecular Therapeutics, Inc.

Equities

FDMT

US35104E1001

Market Closed - Nasdaq Other stock markets 04:00:03 2024-05-31 pm EDT			5-day change	1st Jan Change
24 ^USD	-2.60%		-4.57%	+18.46%

May. 15	Transcript : 4D Molecular Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 03:40 PM
May. 09	4D Molecular Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Transcripts

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : 4D Molecular Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 03:40 PM	May. 14
Transcript : 4D Molecular Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM	Mar. 13
Transcript : 4D Molecular Therapeutics, Inc. - Special Call	Feb. 05
Transcript : 4D Molecular Therapeutics, Inc. - Special Call	Nov. 01
Transcript : 4D Molecular Therapeutics, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 02:00 PM	23-06-12
Transcript : 4D Molecular Therapeutics, Inc. - Special Call	23-06-07
Transcript : 4D Molecular Therapeutics, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 04:20 PM	23-05-09
Transcript : 4D Molecular Therapeutics, Inc. - Special Call	23-04-27
Transcript : 4D Molecular Therapeutics, Inc. - Special Call	23-02-22
Transcript : 4D Molecular Therapeutics, Inc. - Special Call	22-11-14
Transcript : 4D Molecular Therapeutics, Inc. - Special Call	22-11-03
Transcript : 4D Molecular Therapeutics, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-15-2022 08:40 AM	22-06-15
Transcript : 4D Molecular Therapeutics, Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-2022 08:40 AM	22-05-10
Transcript : 4D Molecular Therapeutics, Inc. - Special Call	21-10-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer